Should glucose-sparing prescriptions be expected to reduce the cardiovascular risk of peritoneal dialysis patients?

J Am Soc Nephrol. 2013 Nov;24(11):1713-6. doi: 10.1681/ASN.2013080823. Epub 2013 Aug 29.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Diabetic Nephropathies / therapy*
  • Female
  • Glucose / administration & dosage*
  • Humans
  • Male
  • Peritoneal Dialysis / methods*

Substances

  • Glucose